Results 181 to 190 of about 2,701,090 (280)

Predicting acute aortic syndrome using aortic dissection detection risk score, D-dimer, and X-ray. [PDF]

Heliyon, 2023
Song DH, Choi JH, Lee JY.
europepmc   +1 more source

CD93—An emerging vascular target in cancer therapy

British Journal of Pharmacology, EarlyView.
Abstract CD93 is a single‐pass transmembrane glycoprotein that belongs to the C‐type lectin domain group XIV family of proteins. Although it is known to be expressed in other cell types, namely, in some subsets of immune cells, CD93 is primarily expressed on endothelial cells, where it acts as a crucial regulator of angiogenesis.
Beatriz de Alves Pereira, Stefano Barbera, Roberta Lugano, Anna Dimberg   +3 more
wiley   +1 more source

Applications of Artificial Intelligence as a Prognostic Tool in the Management of Acute Aortic Syndrome and Aneurysm: A Comprehensive Review. [PDF]

J Clin Med
Ayhan C, Mekhaeil M, Channawi R, Ozcan AE, Akargul E, Deger A, Cayan I, Abdalla A, Chan C, Mahon R, Ayhan D, Wijns W, Sultan S, Soliman O.   +13 more
europepmc   +1 more source

Ethnic Disparities in CT Aortography Use for Diagnosing Acute Aortic Syndrome. [PDF]

Radiol Cardiothorac Imaging, 2022
Bhat S, Bir S, Schreve F, Bergin CJ, Jones PG, Waqanivavalagi SWFR.   +5 more
europepmc   +1 more source

Signal detection and characterisation of a novel drug–drug interaction between methadone and a synthetic cannabinoid receptor agonist

British Journal of Pharmacology, EarlyView.
Background and Purpose Little is known about how synthetic cannabinoid receptor agonist (SCRA) co‐use with other psychoactive substances may exacerbate risk of death. This study aimed to characterise the polypharmacy of deaths where SCRAs were detected at post‐mortem, investigate the cardiotoxicity of SCRAs and probe their inhibition of human ether‐a ...
Kirsten L. Rock, Louise M. Hesketh, Hongwei Cheng, Shuoqi Chen, Simon Hudson, Graeme Henderson, Jules C. Hancox, Michael J. Shattock, Michael J. Curtis, Caroline S. Copeland   +9 more
wiley   +1 more source

AI-based diagnosis of acute aortic syndrome from noncontrast CT. [PDF]

Nat Med
Hu Y, Xiang Y, Zhou YJ, He Y, Lang D, Yang S, Du X, Den C, Xu Y, Wang G, Ding Z, Huang J, Zhao W, Wu X, Li D, Zhu Q, Li Z, Qiu C, Wu Z, He Y, Tian C, Qiu Y, Lin Z, Zhang X, Hu L, He Y, Yuan Z, Zhou X, Fan R, Chen R, Chen R, Guo W, Xu J, Zhang J, Mok TCW, Li Z, Kalra MK, Lu L, Xiao W, Li X, Bian Y, Shao C, Wang G, Lu W, Huang Z, Xu M, Zhang H.   +46 more
europepmc   +1 more source

Metabolic remodelling in anthracycline cardiotoxicity: mechanisms and therapeutic insights

British Journal of Pharmacology, EarlyView.
Cardiac metabolic remodelling in anthracycline‐induced cardiomyopathy and metabolically oriented cardioprotective strategies. Schematic representation of substrate utilization, mitochondrial bioenergetic function and metabolic flexibility in the healthy heart, in anthracycline‐induced cardiomyopathy and under potential cardioprotective interventions ...
Giulia Guerra, Francesco Niro, Marco Mergiotti, Giovanni Gavatorta, Emilio Hirsch, Alessandra Ghigo   +5 more
wiley   +1 more source

Development and validation of machine learning-based in-hospital mortality predictive models for acute aortic syndrome in emergency departments. [PDF]

World J Emerg Med
Fu Y, Yang Y, Zhang H, Wang D, Zhai Q, Du L, Muyesai N, Gao Y, Ma Q.   +8 more
europepmc   +1 more source

Evaluation of the Canadian Clinical Practice Guidelines Risk Prediction Tool for Acute Aortic Syndrome: The RIPP Score. [PDF]

Emerg Med Int, 2023
Ohle R, McIsaac S, Van Drusen M, Regis A, Montpellier O, Ludgate M, Bodunde O, Savage DW, Yadav K.   +8 more
europepmc   +1 more source

Targeted delivery of the CB2 receptor agonist JWH‐133 via VCAM‐1‐functionalised nanoparticles attenuates atherosclerosis and reveals sex‐specific therapeutic outcomes

British Journal of Pharmacology, EarlyView.
Background and Purpose Atherosclerosis, a chronic inflammatory disease characterised by lipid accumulation and endothelial dysfunction, remains a leading cause of cardiovascular morbidity and mortality. While cannabinoid 2 (CB2) receptor agonists show therapeutic promise in preclinical studies, their systemic application is hindered by poor ...
Lucía Martín‐Navarro, Lucía Martín‐Banderas, Josefa Álvarez‐Fuentes, María Dolores Herrera‐González   +3 more
wiley   +1 more source